A symposium synopsis *Money Matters: Co-Creating Financial Interventions with Patients, Families, Clinicians, and Communities to Increase Reach Submission Type Symposia Topic Research Submitter Bridgette Thom Affiliation University of North Carolina At Chapel Hill Participant(s) Donald Rosenstein (Co-Chair), Bridgette Thom (Chair), Lauren Ghazal (Speaker), John Salsman (Speaker), Echo Warner (Speaker), Austin Waters (Speaker), Stephanie Wheeler (Speaker), Fumiko Chino (Discussant) SUBMISSION DETAILS Primary Category Social/Practical Problems (resources, financial, insurance, support) Abstract Population Pediatric/AYA, Adult, Geriatric/Aging Adults, Across a Lifespan, Minority and Underserved Overall Symposia Description Cancer-related financial toxicity (FT) can yield negative psychosocial, material, and behavioral impacts on patients and their caregivers. Previous research has produced a robust body of evidence on FT risk factors and consequences. More recently, work has shifted toward prevention and mitigation of FT. Efforts to reduce FT must be informed by the voices of those most impacted-patients and caregivers-and incorporate the perspectives of those clinicians tasked with intervention delivery. In this symposium, we will describe five research studies designed to co-create FT interventions with patients, families, clinicians, and communities.
What does it mean to co-design cancer care 💰🏥 interventions? Who should be involved and how does it work?
Excited to speak today at #APOS2026 as part of this all star panel of #financialToxicity experts.
Starting 10:15am today
Studio 8-9 (2nd Floor)
🙌 Dr @bthomphd.bsky.social
![Screening for Financial Toxicity and Health-Related Social Risks in Patients With Gl Cancer: Results From a Large
Cancer Center
PURPOSE Patients with GI cancers often face significant financial toxicity (FT) and
health-related social risks (HRSRs), yet best practices for screening remain unclear. This study aimed to evaluate the prevalence of FT and HRSR and identify associated factors.
METHODS From June 2022 to August 2023, patients were screened using the Compre-hensive Score for Financial Toxicity (COST), patient-reported HRSR (eg, housing, food insecurity), and quality of life (QOL). Multivariate regressions were used to assess predictors of FT and HRSR, adjusting for several variables.
RESULTS Among 8,335 patients with GI cancer, 45% had a COST score of <26, indicating FT. In adjusted linear regression, FT was associated with racial/ethnic minority status (B, 4.20; P < .001), advanced disease (stage III (B, 1.33; P < .001); IV [B,
1.56; P < .001)), recent treatment (B, 3.23; P < .001), and anal (B, 1.97; P = .003),
esophageal (B, 1.66; P = .005), or hepatobiliary cancer (B, 1.05; P = .031). Older
age (≥65 years [B, -5.17; P < .001)), higher income ($100,000-$200,000 (B, -181; P < .001); >$200,000 [B, -3.80; P < .001)), and private insurance (B, -1.70; P < .001) were protective. Twenty-eight percent reported at least one HRSR. HRSRs were associated with minority status (odds ratio [OR], 2.14;
P < .001), advanced disease (stage III [OR, 1.31; P = .001); IV[OR, 1.24; P = .010)),
recent treatment (OR, 1.20; P = .001), and gastric cancer (OR, 1.25; P = .027).
Lower HRSR was associated with older age (OR, 0.59; P < .001), higher income ($100,000-$200,000 (OR, 0.66; P < .001); >$200,000 (OR, 0.48; P < .001)), and private insurance (OR, 0.64; P < .001). Sex was not a predictor. Worst FT was associated with decreased QOL (B, -0.98; P < .001) and reduced medication adherence (B, 0.11; P < .001).
CONCLUSION High levels of FT and HRSR were observed in patients with GI ca…](https://cdn.bsky.app/img/feed_thumbnail/plain/did:plc:bezfqro7gz4mmrf3yx5wi7gn/bafkreigrnqgkbag2uonhhredzkyqn5kx4ofbrccmoxznu2gaefaai3m3vq)
